ArticleMikrochimica acta2025
An electrochemiluminescence immunosensor for neuron-specific enolase detection based on resonance energy transfer between europium-based metal-organic frameworks and GO-Au composites.
Article in Mikrochimica acta, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
A novel electrochemiluminescence (ECL) immunosensor based on the resonance energy transfer (RET) effect between europium-based metal-organic framework (Eu-MOF, ETM) and GO-PEI/Au was developed for detecting neuron-specific enolase (NSE). First, using 4’,5’-Bis(4-carboxyphenyl)-[1,1’:2’,1”-terphenyl]-4,4”-dicarboxylic acid (TCPB) as the ligand, we synthesized an efficient and stable ECL emitter (ETM) as the signaling substrate. Due to efficient spectral overlap between the ECL emission spectrum of ETM and the UV-vis absorption spectrum of GO-PEI/Au, the ECL emission signal of ETM can be expeditiously quenched. Consequently, the ECL varied with the quenching efficiency of the immunosensor, which correlated with the target analyte concentration, enabling quantitative detection of NSE. The developed straightforward and cost-effective immunosensor exhibited outstanding sensitivity and selectivity in identifying NSE within the 10 fg mL− 1 to 100 ng mL− 1 range with an impressively low limit of detection (LOD) of 1.26 fg mL− 1. The immunosensor was successfully applied to quantify NSE in clinical human serum samples. Furthermore, by substituting the quenching probe, this platform can be readily adapted for detecting diverse biomarkers, demonstrating significant potential utility. To sum up, based on the ECL-RET strategy, a highly sensitive ECL immunosensor for NSE detection was constructed. It incorporated a novel ECL emitter (ETM) and established a new energy donor-acceptor pair, which demonstrated effective preliminary analysis of clinical samples.
Indexed as
Identifiers
41402629What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.